# Circumvent Pharmaceuticals, Inc. — Form C (Regulation Crowdfunding)

Circumvent Pharmaceuticals, Inc. of Portland, OR filed a Form C (Regulation Crowdfunding) with the SEC on 2021-07-12. Target raise $25K, up to $250K. Offered through Bioverge Portal.

## Offering

- Filed: 2021-07-12
- Form: C
- Accession: 0001213900-21-036400
- Target amount: $25K
- Maximum amount: $250K
- Security type: Other
- Securities offered: 25,000
- Price: $25000.0000
- Deadline: 2021-12-31
- Funding portal / intermediary: Bioverge Portal
- Intermediary file number: 007-00157
- Intermediary CRD: 005022636

## Issuer

- CIK: 0001855639
- Website: www.circumventpharmaceuticals.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2015-08-24
- Address: 4640 SW Macadam Ave., Suite 200, Portland, OR, 87239
- Employees: 4

## Financials (as filed)

- Total assets (most recent): $1.7M
- Cash (most recent): $1.7M
- Revenue (most recent): $1K
- Revenue (prior): $906
- Net income (most recent): $-888K
- Net income (prior): $-630K
- Short-term debt: $56K
- Long-term debt: $3.3M

## People (4)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Lim | Chief Executive Officer | Portland, OR |
| Andrew Lim | Director, Chief Executive Officer, and Principal Financial Officer | Portland, OR |
| Samy Hamdouche | Director and Chief Business Officer | Portland, OR |
| Devin Wiley | Director and Chief Medical Officer | Portland, OR |

## More

- [CIK 1855639 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1855639&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001213900-21-036400.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.